Ignite Creation Date:
2025-12-24 @ 11:51 AM
Ignite Modification Date:
2025-12-26 @ 8:09 AM
Study NCT ID:
NCT00873561
Status:
COMPLETED
Last Update Posted:
2009-04-01
First Post:
2009-03-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate NBI-6024 in Adult and Adolescent Patients With New Onset of Type 1 Diabetes Mellitus
Sponsor:
Neurocrine Biosciences
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NBI 6024-0101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Chris O'Brien, Chief Medical Office and VP of Clinical Development
Old Organization:
Neurocrine Biosciences Inc